BCL6 and diffuse large B-cell lymphoma: Consequently, IHC-based methodologies, such as Han’s algorithm [5,6], are widely utilised to classify DLBCL into GCB and non-GCB subtypes, employing three specific biomarkers: CD10, MUM1, and BCL6.